Ezetrol Post-Marketing Study

NCT00753883 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: simvastatin
DRUG: Ezetimibe

Sponsor

Merck Sharp & Dohme LLC